Satvinder Mudan is a highly distinguished surgeon who trained and qualified at St Bartholomew’s Hospital in London. He became a fellow of the Royal College of Surgeons and worked in several prestigious international centres, including the Memorial Sloane-Kettering in New York, the National Cancer Centre in Tokyo, and then as a consultant at St George’s Hospital and the Royal Marsden Hospital in London. 

During this time, he became a leading authority on Gastrointestinal cancer, especially stromal tumours, and the early experience of using immunological agents to treat cancer.

He has a postgraduate Doctorate of Medicine degree from the University of London and researched lipid modification of cell membranes in relation to cytotoxic medication, as well as prostaglandin and essential fatty acid metabolism.

He has extensive experience of the clinical use of mycobacterial agents in cancer, especially melanoma and pancreatic cancer, and helped conduct a phase 2 study into the latter. His observations showing the wellbeing and mood effects on these patients was essential in triggering subsequent research into these organisms.

His main interest now is in the effect of our mycobacteria on chronic inflammation as it relates to cancer, stress, and the gut-brain axis.